GeoVax Labs Statistics
Share Statistics
GeoVax Labs has 9.44M shares outstanding. The number of shares has increased by -68.07% in one year.
| Shares Outstanding | 9.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 237.17% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.39M |
| Failed to Deliver (FTD) Shares | 164.17K |
| FTD / Avg. Volume | 9.76% |
Short Selling Information
The latest short interest is 301.02K, so 3.19% of the outstanding shares have been sold short.
| Short Interest | 301.02K |
| Short % of Shares Out | 3.19% |
| Short % of Float | 3.21% |
| Short Ratio (days to cover) | 0.35 |
Valuation Ratios
The PE ratio is -0.53 and the forward PE ratio is -3.78.
| PE Ratio | -0.53 |
| Forward PE | -3.78 |
| PS Ratio | 0 |
| Forward PS | 1.7 |
| PB Ratio | 2.39 |
| P/FCF Ratio | -0.55 |
| PEG Ratio | n/a |
Enterprise Valuation
GeoVax Labs Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.
| Current Ratio | 2.24 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -4.51% and return on capital (ROIC) is -464.02%.
| Return on Equity (ROE) | -4.51% |
| Return on Assets (ROA) | -2.8% |
| Return on Capital (ROIC) | -464.02% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.53M |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -50.42% in the last 52 weeks. The beta is 3.11, so GeoVax Labs 's price volatility has been higher than the market average.
| Beta | 3.11 |
| 52-Week Price Change | -50.42% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 46.43 |
| Average Volume (20 Days) | 1.68M |
Income Statement
In the last 12 months, GeoVax Labs had revenue of $0 and earned -$25.97M in profits. Earnings per share was $-10.22.
| Revenue | 0 |
| Gross Profit | -20.72M |
| Operating Income | -26.74M |
| Net Income | -25.97M |
| EBITDA | -26.67M |
| EBIT | - |
| Earnings Per Share (EPS) | -10.22 |
Balance Sheet
The company has $6.45M in cash and $0 in debt, giving a net cash position of $6.45M.
| Cash & Cash Equivalents | 6.45M |
| Total Debt | 0 |
| Net Cash | 6.45M |
| Retained Earnings | -104.36M |
| Total Assets | 11.11M |
| Working Capital | 8.26M |
Cash Flow
In the last 12 months, operating cash flow was -$25.17M and capital expenditures -$48.95K, giving a free cash flow of -$25.22M.
| Operating Cash Flow | -25.17M |
| Capital Expenditures | -48.95K |
| Free Cash Flow | -25.22M |
| FCF Per Share | -9.93 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
GOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -434.89% |
| FCF Yield | -113.5% |
Analyst Forecast
The average price target for GOVX is $16.5, which is 602.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.5 |
| Price Target Difference | 602.1% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Jan 31, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | Jan 31, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -16.12 |
| Piotroski F-Score | 3 |